Updated:
PharmaStar Ventures
PharmaStar Ventures is a venture capital based in Taipei, founded 2022; the Altss profile covers its classification, headquarters, registration, AUM band, and...
PharmaStar Ventures
PharmaStar Ventures is a private equity firm based in Taipei, Taiwan. It focuses on a Venture Capital investment approach.
General information
Firm type
Venture Capital
Year founded
2022
Location
Region
Asia
Country
Taiwan
City
Taipei
Corporate office
Taipei, Taiwan
Sector focus
Frequently asked questions
What is PharmaStar Ventures' geographic investment focus?
PharmaStar concentrates on healthcare and life sciences opportunities in Taiwan, the broader Asia-Pacific region, and key biotech hubs in the United States. The firm's Taipei headquarters positions it within Taiwan's established biomedical research cluster. Its cross-border thesis deliberately links Western innovation with Asian clinical development resources and manufacturing scale.
Which healthcare subsectors does PharmaStar prioritize?
PharmaStar's investment lens covers therapeutics — particularly oncology-focused biotechs — precision diagnostics, medical devices, and digital health platforms. Specific areas of known engagement include AI-powered drug discovery platforms and remote patient monitoring systems designed for integration with Asian healthcare delivery networks.
How is PharmaStar Ventures structured relative to other Asian healthcare investors?
PharmaStar operates as a specialized private equity platform rather than a corporate venture arm or a multi-asset family office. Its deliberate cross-border operating thesis — actively bridging portfolio companies with Asian clinical trial networks, regulatory pathways, and contract manufacturing partners — distinguishes it from purely financial healthcare investors in the region.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: